|
93
|
242
|
3up3A |
Nuclear receptor daf-12 from hookworm ancylostoma ceylanicum in complex with (25s)-cholestenoic acid |
|
94
|
269
|
3u9qA |
Ligand binding domain of ppargamma complexed with decanoic acid and pgc-1a peptide |
|
87
|
244
|
3uuaA |
Crystal structure of hera-lbd (y537s) in complex with bisphenol-af |
|
90
|
245
|
3uudA |
Crystal structure of hera-lbd (y537s) in complex with estradiol |
|
79
|
232
|
3uvvB |
Crystal structure of the ligand binding domains of the thyroid receptor:retinoid x receptor complexed with 3,3',5 triiodo-l-thyronine and 9-cis retinoic acid |
|
76
|
240
|
3uucA |
Crystal structure of hera-lbd (wt) in complex with bisphenol-c |
|
88
|
244
|
3uuaB |
Crystal structure of hera-lbd (y537s) in complex with bisphenol-af |
|
89
|
259
|
3uvvA |
Crystal structure of the ligand binding domains of the thyroid receptor:retinoid x receptor complexed with 3,3',5 triiodo-l-thyronine and 9-cis retinoic acid |
|
86
|
245
|
3uu7B |
Crystal structure of hera-lbd (y537s) in complex with bisphenol-a |
|
89
|
244
|
3uu7A |
Crystal structure of hera-lbd (y537s) in complex with bisphenol-a |
|
91
|
247
|
3uudB |
Crystal structure of hera-lbd (y537s) in complex with estradiol |
|
84
|
240
|
3tx7B |
Crystal structure of lrh-1/beta-catenin complex |
|
98
|
277
|
3ty0A |
Structure of ppargamma ligand binding domain in complex with (r)-5-(3-((3-(6-methoxybenzo[d]isoxazol-3-yl)-2-oxo-2,3-dihydro-1h-benzo[d]imidazol-1-yl)methyl)phenyl)-5-methyloxazolidine-2,4-dione |
|
104
|
275
|
3tkmA |
Crystal structure ppar delta binding gw0742 |
|
101
|
254
|
3tkcA |
Design, synthesis, evaluation and structure of vitamin d analogues with furan side chains |
|
102
|
268
|
3t03A |
Crystal structure of ppar gamma ligand binding domain in complex with a novel partial agonist gq-16 |
|
97
|
270
|
3sz1A |
Human ppar gamma ligand binding domain in complex with luteolin and myristic acid |
|
101
|
273
|
3sp6A |
Structural basis for iloprost as a dual pparalpha/delta agonist |
|
107
|
269
|
3sp9A |
Structural basis for iloprost as a dual pparalpha/delta agonist |
|
83
|
229
|
3ruuA |
Fxr with src1 and gsk237 |
|
82
|
228
|
3rvfA |
Fxr with src1 and gsk2034 |
|
98
|
249
|
3ry9A |
Crystal structure of the resurrected ancestral glucocorticoid receptor 1 in complex with doc |
|
87
|
229
|
3rutA |
Fxr with src1 and gsk359 |
|
99
|
247
|
3rljA |
Crystal structure of the androgen receptor ligand binding domain in complex with sarm s-22 |
|
97
|
246
|
3rllA |
Crystal structure of the t877a androgen receptor ligand binding domain in complex with (s)-n-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanonaphthalen-1-yloxy)-2-hydroxy-2-methylpropanamide |
|
93
|
270
|
3r8iA |
Crystal structure of ppargamma with an achiral ureidofibrate derivative (rt86) |
|
92
|
290
|
3r8dA |
Activation of the human nuclear xenobiotic receptor pxr by the reverse transcriptase-targeted anti-hiv drug pnu-142721 |
|
83
|
264
|
3r8aA |
X-ray crystal structure of the nuclear hormone receptor ppar-gamma in a complex with a compound with dual ppar gamma agonism and angiotensin ii type i receptor antagonism activity |
|
97
|
249
|
2oz7A |
Crystal structure of the human androgen receptor t877a mutant ligand-binding domain with cyproterone acetate |
|
78
|
238
|
1lbdA |
Ligand-binding domain of the human nuclear receptor rxr-alpha |
|
103
|
249
|
2q7jA |
The wild type androgen receptor ligand binding domain bound with testosterone and a tif2 box 3 coactivator peptide 740-753 |
|
96
|
239
|
5syzA |
Human liver receptor homologue-1 (lrh-1) bound to a rjw100 stereoisomer and a fragment of tif-2 |
|
90
|
241
|
5c4uA |
Identification of a novel allosteric binding site for rorgt inhibitors |
|
92
|
241
|
5c4sA |
Identification of a novel allosteric binding site for rorgt inhibitors |
|
103
|
290
|
5a86A |
Structure of pregnane x receptor in complex with a sphingosine 1- phosphate receptor 1 antagonist |
|
94
|
254
|
5l7hA |
Mcr in complex with ligand |
|
98
|
260
|
5kyaA |
Brain penetrant liver x receptor (lxr) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core |
|
99
|
273
|
5ji0D |
Ppargamma-rxralpha(s427f) heterodimer in complex with src-1, rosiglitazone, and 9-cis-retanoic acid |
|
85
|
245
|
5krfA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with the dynamic way derivative, 1a |
|
96
|
244
|
5iz0A |
Rorgamma in complex with agonist bio592 and coactivator ebi96 |
|
86
|
244
|
5kraA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with ddt and dde |
|
86
|
242
|
5hjsA |
Identification of lxrbeta selective agonists for the treatment of alzheimer's disease |
|
93
|
229
|
5ickA |
A unique binding model of fxr lbd with feroline |
|
89
|
245
|
5hcvA |
Identification of spirooxindole and dibenzoxazepine motifs as potent mineralocorticoid receptor antagonists |
|
82
|
265
|
5aztA |
Ternary complex of hpparalpha ligand binding domain, 17-oxodha and a src1 peptide |
|
83
|
217
|
5aygA |
Crystal structure of the human ror gamma ligand binding domain with 3g |
|
95
|
246
|
5g46A |
Ligand complex of rorg lbd |
|
92
|
250
|
5gicA |
Crystal structure of vdr in complex with dlam-2p |
|
96
|
249
|
5gidA |
Crystal structure of vdr in complex with dlam-4 (c2 form) |
|
100
|
247
|
5g5wA |
Structure guided design and discovery of indazole ethers as highly potent, non-steroidal glucocorticoid receptor modulators |
